Skip to main content
Premium Trial:

Request an Annual Quote

Product Watch: Enzymatics Sarcoma Fusion Assay

Premium

Enzymatics this week launched a targeted sequencing assay today for detecting and identifying fusions of 26 genes associated with sarcoma.

Using Enzymatics' proprietary anchored multiplex PCR-based enrichment, fusions of all genes in their panel can be identified in a single sequencing run, even without prior knowledge of fusion partners or breakpoints, the company said. The assay will join the ALK, RET, ROS1 v2 panel and the Heme panel as the newest addition to the Archer FusionPlex product line.

FusionPlex assays are target-enrichment assays used to create libraries for next-generation sequencing. They are FFPE-compatible, can be run on Illumina and Ion Torrent NGS platforms, and, in conjunction with Archer Universal RNA Fusion Detection Kits and MBC Adapters, can simultaneously detect and identify specific gene fusions, the company said.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.